Unique ID issued by UMIN | UMIN000030553 |
---|---|
Receipt number | R000034878 |
Scientific Title | Current Status of Primary Malignant Melanoma of Uterus and Ovary in Japan, Retrospective Analysis (KCOG-G1701s) |
Date of disclosure of the study information | 2017/12/25 |
Last modified on | 2023/06/30 14:51:19 |
Current Status of Primary Malignant Melanoma of Uterus and Ovary in Japan, Retrospective Analysis (KCOG-G1701s)
KCOG-G1701s
Current Status of Primary Malignant Melanoma of Uterus and Ovary in Japan, Retrospective Analysis (KCOG-G1701s)
KCOG-G1701s
Japan |
Primary Malignant Melanoma of Uterus and Ovary
Obstetrics and Gynecology |
Malignancy
NO
To clarfy the prognostic factor in primary malignant melanoma of uterus and ovary, we examine the clinicopathological findings and PD-L1 immunohistological expressions.
Others
Retrospective observational study
Prognostic Factors in primary malignant melanoma of uterus and ovary
Observational
Not applicable |
Not applicable |
Female
Patients who received treatment for primary uterine and ovarian malignant melanoma during the 20-year period from April 1997 through March 2017
Metastatic uterine and ovarian malignant melanoma
40
1st name | |
Middle name | |
Last name | Mitsutake Yano |
Saitama Medical University International Medical Center
Department of Pathology
1397-1 Yamane, Hidaka, Saitama 350-1298, Japan
042-984-0609
yano1210@oita-u.ac.jp
1st name | |
Middle name | |
Last name | Mitsutake Yano |
Saitama Medical University International Medical Center
Department of Pathology
1397-1 Yamane, Hidaka, Saitama 350-1298, Japan
042-984-0609
yano1210@oita-u.ac.jp
Kansai Clinical Oncology Group (KCOG)
Kansai Clinical Oncology Group (KCOG)
Self funding
NO
2017 | Year | 12 | Month | 25 | Day |
Unpublished
Completed
2017 | Year | 06 | Month | 24 | Day |
2017 | Year | 06 | Month | 24 | Day |
2017 | Year | 08 | Month | 14 | Day |
2020 | Year | 12 | Month | 31 | Day |
Methods
The survey variables described in Study variables will be entered into Excel worksheets. Excel files will be sent as disks by mail. After data entry, the completed survey questionnaires will be returned to the Study Secretariat by means of self-addressed envelopes.
Survey variables
a. Patient characteristics
Age, body height, body weight, pregnancy and delivery history, past medical history, family medical history, tumor markers, site, Breslow thickness, TNM substage, depth, melanoma subtype, AJCC stage, initial treatment, date of starting treatment, date of completing treatment, presence or absence of recurrence, date of confirming recurrence, treatment for recurrence, survival status, final date of confirming survival
b. Surgical therapy
Uterus and ovary: Simple total hysterectomy, extensive total hysterectomy, radical hysterectomy, salpingo-oophorectomy, tumor resection, lymph-node dissection
c. Radiotherapy
Preoperative, initial, and postoperative radiotherapy: Radiotherapy alone (radiation fields, radiation methods [curative radiation and palliative radiation], total radiation dose, treatment duration, completion rate)
Preoperative, initial, and postoperative chemoradiotherapy: (Radiation fields, radiation methods, total radiation dose, treatment duration, regimen, number of courses, completion rate)
d. Chemotherapy
Preoperative, initial, and postoperative chemotherapy: regimens, number of courses
2017 | Year | 12 | Month | 25 | Day |
2023 | Year | 06 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034878
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |